Drupal.behaviors.print = function(context) {window.print();window.close();}>

Market Malaise, Q2 Financials Weigh on Genomic Tool Vendors' Stocks in July

August 01, 2011

Market Malaise, Q2 Financials Weigh on Genomic Tool Vendors' Stocks in July

The GWDN Index was down 8 percent for the month as a few of the industry's better-known players surprised investors with either disappointing Q2 results or expectations of slower growth for the rest of the year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories